CUSIP 03209R103COMAMPHQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
234 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 5.46M | $146.27M | −23.0K | Reduced |
| 2 | Vanguard Group Inc | 2.61M | $69.85M | −22.9K | Reduced |
| 3 | Td Asset Management Inc | 1.96M | $52.57M | +31.2K | Added |
| 4 | Dimensional Fund Advisors LP | 1.80M | $48.20M |
| +44.0K |
| Added |
| 5 | State Street Corp | 1.53M | $41.02M | +31.0K | Added |
| 6 | Fuller & Thaler Asset Management, Inc. | 1.39M | $37.34M | +40.5K | Added |
| 7 | Marshall Wace, LLP | 1.24M | $33.13M | +363.2K | Added |
| 8 | Epoch Investment Partners, Inc. | 1.13M | $30.17M | −7.4K | Reduced |
| 9 | Boston Trust Walden Corp | 1.09M | $29.12M | −85.8K | Reduced |
| 10 | Geode Capital Management, LLC | 886.8K | $23.75M | −35.8K | Reduced |
See every fund holding Amphastar Pharmaceuticals In, with full quarter-over-quarter share changes.
Unlock all holders